Home › Stocks › APLS › All Fund Holders
APLS — APELLIS PHARMACEUTICALS INC · All Fund Holders
Funds holding (latest): 47 · Reported value held: $2.52B
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| BlackRock Inc history | Q1 2026 | 13.54M | $544.59M | 0.01% | Add |
| Morgan Stanley history | Q1 2026 | 10.04M | $404.01M | 0.03% | Add |
| Vanguard Group history | Q4 2025 | 10.67M | $268.15M | 0.00% | Add |
| UBS Group AG history | Q1 2026 | 6.21M | $249.69M | 0.04% | Add |
| Point72 Asset Management history | Q1 2026 | 4.18M | $168.32M | 0.23% | Add |
| Millennium Management history | Q1 2026 | 2.27M | $91.14M | 0.04% | Add |
| Geode Capital Management history | Q1 2026 | 2.08M | $83.50M | 0.01% | Add |
| Goldman Sachs Group history | Q1 2026 | 1.98M | $79.66M | 0.01% | Add |
| Balyasny Asset Management history | Q1 2026 | 1.92M | $77.14M | 0.10% | Add |
| Viking Global Investors history | Q3 2022 | 932.44K | $63.69M | 0.31% | New |
| Bank of America Corp history | Q1 2026 | 1.19M | $47.91M | 0.00% | Add |
| Fidelity International (FIL) history | Q1 2026 | 1.14M | $45.86M | 0.04% | New |
| Soros Fund Management history | Q1 2026 | 1.06M | $42.48M | 0.50% | New |
| Renaissance Technologies history | Q1 2026 | 935.96K | $37.65M | 0.06% | Add |
| Marshall Wace history | Q1 2026 | 929.02K | $37.37M | 0.04% | Reduce |
| Norges Bank Investment Management history | Q4 2025 | 1.20M | $30.10M | 0.00% | Reduce |
| Northern Trust Corp history | Q1 2026 | 738.44K | $29.71M | 0.00% | Add |
| Charles Schwab Investment Management history | Q1 2026 | 675.86K | $27.19M | 0.00% | Add |
| BNY Mellon history | Q1 2026 | 524.79K | $21.11M | 0.00% | Add |
| Two Sigma Investments history | Q1 2026 | 521.97K | $21.00M | 0.02% | Reduce |
| Principal Global Investors history | Q1 2026 | 499.05K | $20.08M | 0.01% | New |
| Invesco Ltd history | Q1 2026 | 437.87K | $17.62M | 0.00% | Add |
| AQR Capital Management history | Q1 2026 | 427.97K | $17.22M | 0.01% | Reduce |
| PSP Investments history | Q1 2026 | 366.67K | $14.75M | 0.05% | New |
| Arrowstreet Capital history | Q3 2021 | 418.54K | $13.79M | 0.02% | New |
| Citadel Advisors history | Q1 2026 | 263.29K | $10.59M | 0.00% | Reduce |
| Janus Henderson Group history | Q1 2026 | 252.13K | $10.14M | 0.01% | Add |
| Wellington Management Group history | Q1 2026 | 249.63K | $10.04M | 0.00% | Reduce |
| Legal & General Investment Management America history | Q1 2026 | 228.25K | $9.18M | 0.00% | Add |
| Moore Capital Management history | Q3 2023 | 150.00K | $5.71M | 0.11% | Add |
| D. E. Shaw & Co history | Q1 2026 | 5.00M | $5.30M | 0.00% | Hold |
| Deutsche Bank AG history | Q1 2026 | 95.36K | $3.84M | 0.00% | Reduce |
| Prudential Financial history | Q1 2026 | 92.51K | $3.72M | 0.01% | New |
| PNC Financial Services history | Q1 2026 | 54.47K | $2.19M | 0.00% | Add |
| Bridgewater Associates history | Q1 2026 | 34.91K | $1.40M | 0.01% | Reduce |
| Amundi US history | Q1 2026 | 30.72K | $1.24M | 0.00% | Hold |
| Manulife Financial history | Q1 2026 | 24.77K | $996.30K | 0.00% | Add |
| CPP Investments history | Q1 2026 | 19.60K | $788.51K | 0.00% | Reduce |
| Franklin Resources history | Q1 2026 | 11.38K | $457.82K | 0.00% | Add |
| JPMorgan Chase & Co history | Q4 2025 | 15.00K | $376.80K | 0.00% | Reduce |
| Wells Fargo & Co history | Q1 2026 | 8.59K | $345.65K | 0.00% | Reduce |
| Farallon Capital Management history | Q1 2026 | 6.00K | $241.38K | 0.00% | New |
| Fidelity Management & Research (FMR) history | Q1 2026 | 5.56K | $223.80K | 0.00% | Reduce |
| Baillie Gifford & Co history | Q1 2023 | 325 | $21.44K | 0.00% | Add |
| Citigroup Inc history | Q1 2026 | 6.00K | $6.30K | 0.00% | Hold |
| T. Rowe Price Associates history | Q1 2026 | 106.91K | $4.30K | 0.00% | Add |
| Lazard Asset Management history | Q2 2025 | 1.02K | $17 | 0.00% | Reduce |